Navigation Links
Abbott Study Examines Rates of Uveitis (Inflammation of the Eye) in Ankylosing Spondylitis Patients Treated with HUMIRA(R) (adalimumab)
Date:11/8/2007

ammation of the spine. Ankylosing means "stiff or rigid" and spondylitis means "inflammation of the spine." Advanced AS can lead to new bone formation on the spine causing the spine to fuse in a fixed position. Typically, the first symptoms of AS are gradual and can include frequent pain and stiffness in the lower back and buttocks. In addition to back pain, other symptoms can include inflammation of joints or tendons, weight loss, fatigue, and eye inflammation (uveitis).

AS affects an estimated 129 out of 100,000 people in the United States and commonly develops between the ages of 15 and 40. Men are three times more likely than women to develop AS. Although the course and severity of AS varies from person to person, some patients with progressive AS can develop spinal deformities leading to significant disability.

The cause of AS is not known, though genetics may play a role: 90 percent of people with AS share a common genetic marker, but having this genetic marker does not mean a person will develop the disease.

Important Safety Information

Serious infections, sepsis, tuberculosis (TB) and opportunistic infections, including fatalities, have been reported with the use of TNF-blocking agents, including HUMIRA. Many of these serious infections have occurred in patients also taking other immunosuppressive agents that in addition to their underlying disease could predispose them to infections. Infections have also been reported in patients receiving HUMIRA alone. Treatment with HUMIRA should not be initiated in patients with active infections. TNF-blocking agents, including HUMIRA, have been associated with reactivation of hepatitis B (HBV) in patients who are chronic carriers of this virus. Some cases have been fatal. Patients at risk for HBV infections should be evaluated for prior evidence of HBV infections before initiating HUMIRA. The combination of HUMIRA and anakinra is not recommended and patients using HUMIRA should not receive live v
'/>"/>

SOURCE Abbott
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Abbott to Present at Bear Stearns Healthcare Conference
2. The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events
3. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
4. Abbott Declares 335th Consecutive Quarterly Dividend
5. Abbott Again Honored as Top Company for Working Moms
6. Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
7. Abbott Hosts Conference Call for Third-Quarter Earnings
8. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
9. Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine
10. Abbott Again Honored as a Leader in Diversity
11. Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2014)... Fe, New Mexico (PRWEB) August 31, 2014 ... a Disability Rights friend-of-the-court brief in support of the ... district court ruling that the New Mexico constitution contains ... No. 33,630, Court of Appeals of the State of ... joined in the brief: ADAPT, the American Association ...
(Date:8/31/2014)... 31, 2014 Kicking blog MichaelHusted.com ... Nelson of Matt Nelson Kicking Academy on his role ... being a National Camp Series (NCS) Associate according to ... "Matt Nelson is another high quality to our NCS ... coaching. He is an outstanding pro prospect kicker, ...
(Date:8/31/2014)... 31, 2014 The severity of menopausal ... specializing in menopause is expert in helping patients ... relief from uncomfortable symptoms with the latest treatment options, ... offer a variety of alternative treatments and products that ... treatment options may fall outside of what can be ...
(Date:8/30/2014)... 2014: A new method to predict the optimal ... presented at ESC Congress today by Dr Benjamin Dahan ... 350 AEDs located in public places for optimal prevention ... Dahan said: "Out of hospital cardiac arrest is a ... between 50 and 100 per 100 000 in the ...
(Date:8/30/2014)... August 31, 2014 According to the latest ... by step holistic system for skin health. It seems that ... been tried by more than 138,000 patients from all over ... Walden, who says that this method will not only eliminate ... skin. , What makes this program unique among other ...
Breaking Medicine News(10 mins):Health News:Not Dead Yet and Six Other National Disability Groups Submit Friend-of-the-Court Brief in New Mexico Assisted Suicide Appeal 2Health News:Not Dead Yet and Six Other National Disability Groups Submit Friend-of-the-Court Brief in New Mexico Assisted Suicide Appeal 3Health News:MichaelHusted.com Features an Interview with Matt Nelson of Matt Nelson Kicking Academy on His Role as a Kicking Coach and on Becoming a National Camp Series Associate 2Health News:MichaelHusted.com Features an Interview with Matt Nelson of Matt Nelson Kicking Academy on His Role as a Kicking Coach and on Becoming a National Camp Series Associate 3Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 2Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 3Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 4Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 5Health News:New method predicts optimal number and location of AEDs 2Health News:Acne No More Review Reveals Unusual Tip to Eliminate Acne Permanently 2
... NEW YORK, Feb. 26 With sensational headlines about multiple ... fact that infertility is a painful reality for many couples ... million Americans struggle with fertility issues, and the number is ... has doubled in size and now exceeds $3 billion. ...
... As the voice of the global clinical ... (ACRO) had the honor of presenting before the ... 2009 in Tokyo. ACRO Chair Derek Winstanly, MBChB, ... ACRO Executive Director Douglas Peddicord, Ph.D. addressed "Representing ...
... number of potential medicines to treat heart disease and ... by the Pharmaceutical Research and Manufacturers of America (PhRMA) ... medicines to treat these diseases currently are being tested ... the U.S. Food and Drug Administration, compared to 146 ...
... Secure Message Capability to Facilitate Instant Collaborative ... Science, Inc. (HSI), a Rockville Innovation Center ... an innovative software service that enables physicians ... a secure environment. PatientCarenet.Org connects community-based ...
... as keys to successLAS VEGAS, Feb. 26 The ... ) (AAOS) is honored to recognize a surgeon who has ... backgrounds to pursue the orthopaedic specialty and who has never ... presented today with the Academy,s Diversity Award at its 2009 ...
... first considered a life in medicine at the ripe old ... and tribulations of a young television doctor named Ben Casey. ... sparked an idea which led to an impressive and successful ... Zuckerman was named President of the American Academy of ...
Cached Medicine News:Health News:A Recession-Resistant Business? Introducing FertilityAuthority.com 2Health News:ACRO Presents at Japan CRO Association Commemorative Symposium 2Health News:Record Number of Innovative New Medicines for Heart Disease and Stroke Now in Development 2Health News:Record Number of Innovative New Medicines for Heart Disease and Stroke Now in Development 3Health News:Human Science, Inc. Launches PatientCarenet.Org 2Health News:Human Science, Inc. Launches PatientCarenet.Org 3Health News:Ramon L. Jimenez, MD: A Diverse Life 2Health News:Ramon L. Jimenez, MD: A Diverse Life 3Health News:Joseph D. Zuckerman, M.D., Elected President of the American Academy of Orthopaedic Surgeons 2Health News:Joseph D. Zuckerman, M.D., Elected President of the American Academy of Orthopaedic Surgeons 3
(Date:8/29/2014)... DUBLIN , Aug. 29, 2014 ... the "Global Peptide Cancer Therapeutics Market & Pipeline ... The conventional methods developed to prevent and eradicate ... cancer treatment. These methods are confined to low specificity, ... the researchers to look for a better solution. It ...
(Date:8/29/2014)... 29, 2014 According to ... by Extraction type (SFE, Cold Pressed, Organic Solvent, & ... Pharmaceutical, Food Supplements, Fragrance, & Others) - Global Trends ... and segments the Amaranth Seed Oil Market with ... in terms of value. The Amaranth Seed Oil ...
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "Research and Development Trend Forecast of Pharmaceutical Equipment ... Research and Development Trend Forecast of ... 2014-2018 mainly analyzes China,s pharmaceutical ... supply & demand, competition landscape, and business performance of ...
Breaking Medicine Technology:Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2
... 10, 2011 Amgen today announced that five inspirational cancer survivors ... their communities have been selected as Breakaway from Cancer ... The five Breakaway from Cancer Champions were ... this year. The 2011 Breakaway from Cancer Champions are: ...
... COLUMBUS, Ohio, May 10, 2011 Taylor Strategy Partners (TSP), who ... the best human capital for their organizations, is pleased to announce ... TSP was founded in 1969 and is headquartered in Columbus, OH ... Radloff, TSP Vice President and Managing Director, will be taking the ...
Cached Medicine Technology:Five Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California 2Five Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California 3Five Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California 4Taylor Strategy Partners Set to Open Office in Kansas City in June 2011 2
Now available in 2.75-mm diameters, the S660 small vessel coronary stent expands your treatment options for accurate sizing and precision stenting....
Rapid Exchange Stent Delivery System...
The MULTI-LINK PIXEL Coronary Stent System was designed to address the challenges of small vessel treatment in patients with abrupt or threatened abrupt closure (ATC)....
IVUS console...
Medicine Products: